Caricamento...
Fluorescence-guided Resection of Experimental Malignant Glioma Using Cetuximab-IRDye 800CW
The standard treatment for Glioblastoma Multiforme (GBM) remains maximal safe surgical resection. Here, we evaluated the ability of a systemically administered antibody-dye probe conjugate (cetuximab-IRDye 800CW) to provide sufficient fluorescent contrast for surgical resection of disease in both su...
Salvato in:
| Pubblicato in: | Br J Neurosurg |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4740249/ https://ncbi.nlm.nih.gov/pubmed/26073144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02688697.2015.1056090 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|